← Back to results
Federal

Protecting Families from Fertility Fraud Act of 2023

Source: Congress.gov  ·  823 words in original text
This bill creates a new federal crime for people who knowingly lie about the DNA used in fertility treatments. The law applies when the misrepresentation involves assisted reproductive technology (medical procedures that handle human eggs or embryos) or assisted insemination (procedures that handle sperm). The bill is called the Protecting Families from Fertility Fraud Act of 2023.
People who perform fertility treatments and knowingly misrepresent DNA sources. Patients and families receiving fertility treatments. Federal prosecutors and courts enforcing the new law.
- Anyone who knowingly misrepresents the nature or source of DNA used in assisted reproductive technology or assisted insemination faces fines, imprisonment for up to 10 years, or both (Sec. 2(a)). - The federal crime applies when someone traveled across state or international borders in connection with the conduct, or when someone used interstate or foreign communication methods (such as mail, phone, or computer) to further the misrepresentation (Sec. 2(b)). - The crime applies when any payment involved in the conduct used interstate or foreign commerce channels, or when any tools or items that traveled across state or international borders were used to perform the misrepresentation (Sec. 2(b)). - When DNA testing identifies a person who committed this crime, prosecutors have 10 years from the date of identification to bring charges, even if normal time limits would otherwise prevent prosecution (Sec. 2(c)). - This new crime is added to the list of crimes considered racketeering activity (organized crime patterns involving multiple predicate crimes) (Sec. 2(b)).
Federal law will newly criminalize knowingly misrepresenting DNA sources in fertility treatments. A specific statute (Section 2249) is added to title 18 of the United States Code. The crime becomes actionable in federal court when it involves interstate or foreign commerce connections.
Assisted reproductive technology: medical treatment or procedures that involve handling human eggs or embryos, such as in vitro fertilization (creating embryos outside the body), gamete intrafallopian transfer (placing eggs and sperm in the fallopian tube), and zygote intrafallopian transfer (placing fertilized eggs in the fallopian tube). Assisted insemination: any procedure involving handling of sperm, including intrauterine insemination (placing sperm directly in the uterus).
Not specified in bill text
Important: This plain English summary was generated by AI and is provided for informational purposes only. It is not legal advice. Always consult the official bill text on Congress.gov or a qualified attorney for legal matters.